• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

February 7-8, 2017 NVAC Meeting

February 7, 2017 - February 8, 2017

The Great Hall, Humphrey Building
200 Independence Avenue, S.W.
Washington, DC 20201

Agenda

Day 1 – Tuesday, February 7th

Time Agenda Item Presenter(s)
9:20 – 10:00 a.m. Welcome  
9:20 a.m. Welcome by the Principal Deputy Assistant Secretary for Health and Outgoing Member Appreciation Dr. Bruce Gellin, Director, NVPO
Dr. Jewel Mullen, Acting Assistant Secretary for Health
9:50 a.m. Chair’s Updates Dr. Kim Thompson, NVAC Chair
10:00 – 11:30 a.m. NVAC at 30  
10:00 a.m. Remarks from NVPO Dr. Bruce Gellin, Director, NVPO
10:05 a.m. National Vaccine Program and National Vaccine Advisory Committee: Beginnings and Highlights Dr. Alan Hinman, Senior Advisor, Center for Vaccine Equity, Task Force for Global Health
10:35 a.m. NVAC and the Future of Vaccinology Dr. Stanley Plotkin, Emeritus Professor, University of Pennsylvania
11:05 a.m. Discussion  
11:30 – 11:45 a.m. Break  
11:45 – 1:00 p.m. Vaccine Safety Science and Personalized Vaccinology  
11:45 a.m. The Case for Personalized Vaccinology in the 21st Century Dr. Gregory Poland, Mary Lowell Leary Emeritus Professor of Medicine, Distinguished Mayo Investigator, Director, Mayo Vaccine Research Group, Mayo Clinic
12:05 p.m. Metabolites as Biomarkers of Adverse Reactions Following Vaccination: A Pilot Study using Nuclear Magnetic Resonance Metabolomics Dr. Bruce McClenathan, Regional Medical Director, Defense Health Agency, DoD
12:25 p.m. (Almost) All Immunity is Local—Implications for Vaccines from Tissue Immunodynamics Dr. Chuck Hackett, Deputy Director of the Division of Allergy, Immunology, and Transplantation, NIAID
12:45 p.m. Discussion  
1:00 – 2:00 p.m. Lunch  
2:00 – 2:45 p.m. Vaccine Delivery Systems  
2:00 p.m. Innovative Vaccine Delivery Technologies: New Paradigms for Immuno-protective Countermeasures Dr. Jonathan Seals, Director, Strategic Science and Technology, BARDA
2:30 p.m. Discussion  
2:45 – 3:45 p.m. NVAC MCR Working Group (WG): Findings, Recommendations, and Voting  
2:45 p.m. Summary Presentation Dr. Yvonne Maldonado, NVAC
Dr. Nate Smith, NVAC
3:15 p.m. Discussion  
3:30 p.m. Public Comment  
3:40 p.m. Vote  
3:45 – 4:00 p.m. Break  
4:00 – 5:00 p.m. Updates on Mumps Outbreaks  
4:00 p.m. Mumps Epidemiology and Public Health Response in Minnesota Dr. Ruth Lynfield, NVAC
4:20 p.m. Update on Mumps Outbreaks: Arkansas Dr. Nate Smith, NVAC
4:40 p.m. Update on Mumps Outbreaks: CDC Dr. Nancy Messonnier, CDC
4:50 p.m. Discussion  
5:00pm– 5:15pm Public Comment  
5:15 p.m. Adjourn  

Day 2 – Wednesday, February 8th

Time Agenda Item Presenter(s)
9:00 – 9:05 a.m. Welcome and Wrap-up from Previous Day Dr. Kim Thompson, NVAC Chair
9:05 – 10:00 a.m. Zika Vaccine Development  
9:05 a.m. Zika Virus Epidemiology Update Dr. Marc Fischer, Medical Epidemiologist, DVBD, NCEZID, CDC
9:25 a.m. Overview: Zika Vaccines in Development Dr. Gerald Kovacs, Senior Advisor, BARDA, ASPR
9:45 a.m. Discussion  
10:00 – 10:30 a.m. Vaccines in the 21 Century Cures Act  
10:00 a.m. Vaccine Innovation Dr. Bruce Gellin, Director, NVPO
10:05 a.m. Impact on VICP Dr. Narayan Nair, HRSA
10:10 a.m. Impact on CDC Dr. Nancy Messonnier, CDC
10:15 a.m. Additional Comments from NIH and FDA Dr. Barbara Mulach, NIH
Dr. Marion Gruber, FDA
10:25 a.m. Discussion  
10:30 – 10:45am Break  
10:45 – 12:15pm NVAC Liaison and Ex Officio Updates  
10:45 a.m. Selected Highlights of Ex-Officios and Liaison Activities Dr. Rhonda Kropp, PHAC
Mr. Troy Knighton, VA
Dr. Nancy Messonnier, CDC
11:15 a.m. Discussion  
11:30 a.m. Liaison Members ACCV, ACIP, AHIP, AIM, AIRA, ASTHO, NACCHO, PAHO, PHAC, VRBPAC
11:50 a.m. Ex Officio Members AHRQ, ASPR, CDC, CMS, DoD, FDA, HRSA-BPHC, HRSA-DICP, IHS, NIH, USDA, VA
12:15 – 12:45 p.m. Childhood Immunizations: Taking the Pulse of the Public  
12:15 p.m. Public Views about the MMR Vaccine and Trust in Medical Scientists and their Research on Childhood Vaccines Dr. Cary Funk, Associate Director, Research on Science and Society Pew Research Center
12:35 p.m. Discussion  
12:45 – 1:00 p.m. Public Comment  
1:00 p.m. Adjourn  

Abbreviations

ACCV — Advisory Commission on Childhood Vaccines

ACIP — Advisory Committee on Immunization Practices

AHIP — America’s Health Insurance Plans

AHRQ — Agency for Healthcare Research and Quality

AIM — Association of Immunization Managers

AIRA — American Immunization Registry Association

ASPR — Assistant Secretary for Preparedness and Response

ASTHO — Association of State and Territorial Health Officials

BARDA — Biomedical Advanced Research and Development Authority

CDC — Centers for Disease Control and Prevention

CMS — Centers for Medicare and Medicaid Services

DoD — Department of Defense

DVBD — Division of Vector-Borne Diseases

FDA — Food and Drug Administration

HRSA — Health Resources and Services Administration

IHS — Indian Health Services

NACCHO — National Association of County and City Health Officials

NCEZID — National Center for Emerging and Zoonotic Infectious Diseases

NIAID — National Institute of Allergy and Infectious Diseases

NIH — National Institutes of Health

PAHO — Pan American Health Organization

PHAC — Public Health Agency of Canada

USDA — U.S. Department of Agriculture

VA — Department of Veterans Affairs

VRBPAC — Vaccines and Related Biological Products Advisory Committee